Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T66925 | Target Info | |||
| Target Name | Coagulation factor XIIIA (F13A1) | ||||
| Synonyms | Transglutaminase A chain; Protein-glutamine gamma-glutamyltransferase A chain; F13A; Coagulation factor XIII A chain | ||||
| Target Type | Patented-recorded Target | ||||
| Gene Name | F13A1 | ||||
| Biochemical Class | Acyltransferase | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| United States Patent and Trademark Office (USPTO) | |||||
| Patent ID | US2003225007 | ||||
| Title | Sulfonamide Derivatives of 3-Substituted Imidazol[1,2-D]-1,2,4-Thiadiazoles and 3-Substituted-[1,2,4] Thiadiazolo [4,5-A] Benzimidazole As Inhibitors of Fibrin Cross-Linking and Transglutamin. | ||||
| Applicant(s) | Apotex Inc | ||||
| Representative Drug(s) | D0KK6L | Drug Info | N.A. | [1] | |
| Patent ID | US6025330 | ||||
| Title | Inhibitors of Fibrin Cross-Linking and/or Transglutaminases. | ||||
| Applicant(s) | Biopharm Research & Development | ||||
| European Patent Office (EPO) | |||||
| Patent ID | EP1458866 | ||||
| Title | Modified Tridegins, Production and Use Thereof As Transglutaminase Inhibitors. | ||||
| Applicant(s) | Curacyte Ag | ||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Transglutaminase inhibitors: a patent review.Expert Opin Ther Pat. 2016;26(1):49-63. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.